A Decision Analytics Model to Optimize Investment in Interventions Targeting the HIV PrEP Cascade of Care
Preprint
Abstract
Objectives: Gaps between recommended and actual levels of HIV preexposure prophylaxis (PrEP) use remain among men who have sex with men (MSM). Interventions can address these gaps, but it is unknown how public health initiatives should invest prevention funds into these interventions to maximize their population impact. Design: We used a stochastic network-based HIV transmission model for MSM in the Atlanta area paired with an economic budget optimization model. Methods: The model simulated MSM participating in up to three real-world PrEP cascade interventions designed to improve initiation, adherence, or persistence. The primary outcome was infections averted over 10 years. The budget optimization model identified the investment combination under different budgets that maximized this outcome given intervention costs from a payer perspective. Results: From the base 15% PrEP coverage level, the three interventions could increase coverage to 27%, resulting in 12.3% of infections averted over 10 years. Uptake of each intervention was interdependent: maximal use of the adherence and persistence interventions depended on new PrEP users generated by the initiation intervention. As the budget increased, optimal investment involved a mixture of the initiation and persistence interventions, but not the adherence intervention. If adherence intervention costs were halved, the optimal investment was roughly equal across interventions. Conclusions: Investments into the PrEP cascade through initiatives should account for the interactions of the interventions as they are collectively deployed. Given current intervention efficacy estimates, the total population impact of each intervention may be improved with greater total budgets or reduced intervention costs.Keywords
All Related Versions
- Published version: AIDS, 35 (9), 1479.
This publication has 25 references indexed in Scilit:
- The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis–to-need ratio in the fourth quarter of 2017, United StatesAnnals of Epidemiology, 2018
- Developing and Assessing the Feasibility of a Home-based Preexposure Prophylaxis Monitoring and Support ProgramClinical Infectious Diseases, 2018
- Estimated Coverage to Address Financial Barriers to HIV Preexposure Prophylaxis Among Persons With Indications for Its Use, United States, 2015JAIDS Journal of Acquired Immune Deficiency Syndromes, 2017
- Optimizing Pre-Exposure Antiretroviral Prophylaxis Adherence in Men Who Have Sex with Men: Results of a Pilot Randomized Controlled Trial of “Life-Steps for PrEP”AIDS and Behavior, 2016
- Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United StatesThe Journal of Infectious Diseases, 2016
- Towards an integrated primary and secondary HIV prevention continuum for the United States: a cyclical process modelJournal of the International AIDS Society, 2016
- Retention in care outcomes for HIV pre‐exposure prophylaxis implementation programmes among men who have sex with men in three US citiesJournal of the International AIDS Society, 2016
- Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health ServicesJAMA Internal Medicine, 2016
- Applying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, GeorgiaClinical Infectious Diseases, 2015
- Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort studyThe Lancet Infectious Diseases, 2014